<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39309669</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1520-6750</ISSN><JournalIssue CitedMedium="Internet"><Volume>71</Volume><Issue>7</Issue><PubDate><Year>2024</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Naval research logistics</Title><ISOAbbreviation>Nav Res Logist</ISOAbbreviation></Journal><ArticleTitle>Optimization Modeling for Pandemic Vaccine Supply Chain Management: A Review and Future Research Opportunities.</ArticleTitle><Pagination><StartPage>976</StartPage><EndPage>1016</EndPage><MedlinePgn>976-1016</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/nav.22181</ELocationID><Abstract><AbstractText>During various stages of the COVID-19 pandemic, countries implemented diverse vaccine management approaches, influenced by variations in infrastructure and socio-economic conditions. This article provides a comprehensive overview of optimization models developed by the research community throughout the COVID-19 era, aimed at enhancing vaccine distribution and establishing a standardized framework for future pandemic preparedness. These models address critical issues such as site selection, inventory management, allocation strategies, distribution logistics, and route optimization encountered during the COVID-19 crisis. A unified framework is employed to describe the models, emphasizing their integration with epidemiological models to facilitate a holistic understanding. This article also summarizes evolving nature of literature, relevant research gaps, and authors' perspectives for model selection. Finally, future research scopes are detailed both in the context of modeling and solutions approaches.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dey</LastName><ForeName>Shibshankar</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Industrial Engineering and Management Sciences, Northwestern University, Evanston, IL, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Engineering and Health, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kurbanzade</LastName><ForeName>Ali Kaan</ForeName><Initials>AK</Initials><AffiliationInfo><Affiliation>Department of Industrial Engineering and Management Sciences, Northwestern University, Evanston, IL, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Engineering and Health, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gel</LastName><ForeName>Esma S</ForeName><Initials>ES</Initials><AffiliationInfo><Affiliation>Department of Supply Chain Management and Analytics, University of Nebraska-Lincoln, Lincoln, NB, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mihaljevic</LastName><ForeName>Joseph</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>School of Informatics, Computing, and Cyber Systems, Northern Arizona University, Flagstaff, AZ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mehrotra</LastName><ForeName>Sanjay</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Industrial Engineering and Management Sciences, Northwestern University, Evanston, IL, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Engineering and Health, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AI168144</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>04</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Nav Res Logist</MedlineTA><NlmUniqueID>100913823</NlmUniqueID><ISSNLinking>0894-069X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19 vaccine management</Keyword><Keyword MajorTopicYN="N">epidemiological modeling</Keyword><Keyword MajorTopicYN="N">mathematical modeling</Keyword><Keyword MajorTopicYN="N">review</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>10</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>23</Day><Hour>7</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>23</Day><Hour>7</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>23</Day><Hour>5</Hour><Minute>53</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39309669</ArticleId><ArticleId IdType="mid">NIHMS1977187</ArticleId><ArticleId IdType="pmc">PMC11412613</ArticleId><ArticleId IdType="doi">10.1002/nav.22181</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Abbasi B, Fadaki M, Kokshagina O, Saeed N, and Chhetri P (2020). Modeling vaccine allocations in the COVID-19 Pandemic: A case study in Australia. Available at SSRN 3744520, 10.2139/ssrn.3744520.</Citation><ArticleIdList><ArticleId IdType="doi">10.2139/ssrn.3744520</ArticleId></ArticleIdList></Reference><Reference><Citation>Abbasi S, Zahmatkesh S, Bokhari A, and Hajiaghaei-Keshteli M (2023). Designing a vaccine supply chain network considering environmental aspects. Journal of Cleaner Production 417, 137935, 10.1016/j.jclepro.2023.137935.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclepro.2023.137935</ArticleId></ArticleIdList></Reference><Reference><Citation>Alam ST, Ahmed S, Ali SM, Sarker S, Kabir G, et al. (2021). Challenges to COVID-19 Vaccine supply chain: Implications for sustainable development goals. International Journal of Production Economics 239, 108–193, 10.1016/j.ijpe.2021.108193.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijpe.2021.108193</ArticleId><ArticleId IdType="pmc">PMC8184405</ArticleId><ArticleId IdType="pubmed">34121813</ArticleId></ArticleIdList></Reference><Reference><Citation>Anahideh H, Kang L, and Nezami N (2022). Fair and diverse allocation of scarce resources. Socio-Economic Planning Sciences 80, 101–193, 10.1016/j.seps.2021.101193.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.seps.2021.101193</ArticleId><ArticleId IdType="pmc">PMC8597936</ArticleId><ArticleId IdType="pubmed">34812203</ArticleId></ArticleIdList></Reference><Reference><Citation>Assi T-M, Brown ST, Djibo A, Norman BA, Rajgopal J, Welling JS, Chen S-I, Bailey RR, Kone S, Kenea H, et al. (2011). Impact of changing the Measles Vaccine vial size on Niger’s vaccine supply chain: A computational model. BMC Public Health 11(1), 1–9, 10.1186/1471--2458--11--425.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471--2458--11--425</ArticleId><ArticleId IdType="pmc">PMC3129313</ArticleId><ArticleId IdType="pubmed">21635774</ArticleId></ArticleIdList></Reference><Reference><Citation>Assi T-M, Rookkapan K, Rajgopal J, Sornsrivichai V, Brown ST, Welling JS, Norman BA, Connor DL, Chen S-I, Slayton RB, et al. (2012). How Influenza Vaccination policy may affect vaccine logistics. Vaccine 30(30), 4517–4523, 10.1016/j.vaccine.2012.04.041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2012.04.041</ArticleId><ArticleId IdType="pmc">PMC3592980</ArticleId><ArticleId IdType="pubmed">22537993</ArticleId></ArticleIdList></Reference><Reference><Citation>Azadi Z, Eksioglu SD, and Geismar HN (2020). Optimization of distribution network configuration for pediatric vaccines using chance constraint programming. arXiv preprint arXiv:2006.05488, 10.48550/arXiv.2006.05488.</Citation><ArticleIdList><ArticleId IdType="doi">10.48550/arXiv.2006.05488</ArticleId></ArticleIdList></Reference><Reference><Citation>Azadi Z, Gangammanavar H, and Eksioglu S (2020). Developing childhood vaccine administration and inventory replenishment policies that minimize open vial wastage. Annals of Operations Research 292(1), 215–247, 10.1007/s10479--019--03164--8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10479--019--03164--8</ArticleId></ArticleIdList></Reference><Reference><Citation>Balcik B, Yucesoy E, Akca B, Karakaya S, Gevsek AA, Baharmand H, and Sgarbossa F (2022). A mathematical model for equitable in-country COVID-19 Vaccine allocation. International Journal of Production Research, 1–25, 10.1080/00207543.2022.2110014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00207543.2022.2110014</ArticleId></ArticleIdList></Reference><Reference><Citation>Bandi C, Gao SY, Moorthy R, Tan KB, and Teo C-P (2021). Optimal scheduling and policy design of two-dose vaccination rollout. pp. 10.2139/ssrn.3909792.</Citation><ArticleIdList><ArticleId IdType="doi">10.2139/ssrn.3909792</ArticleId></ArticleIdList></Reference><Reference><Citation>Barth J, Li S, Aprahamian H, and Gupta D (2023). Spatiotemporal vaccine allocation policies for epidemics with behavioral feedback dynamics. Naval Research Logistics (NRL), 10.1002/nav.22142.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/nav.22142</ArticleId></ArticleIdList></Reference><Reference><Citation>Basciftci B, Yu X, and Shen S (2023). Resource distribution under spatiotemporal uncertainty of disease spread: Stochastic versus robust approaches. Computers &amp; Operations Research 149, 106028, 10.1016/j.cor.2022.106028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cor.2022.106028</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennouna A, Joseph J, Nze-Ndong D, Perakis G, Singhvi D, Lami OS, Spantidakis Y, Thayaparan L, and Tsiourvas A (2022). COVID-19 prediction, prevalence, and the operations of vaccine allocation. Manufacturing &amp; Service Operations Management, 10.1287/msom.2022.1160.</Citation><ArticleIdList><ArticleId IdType="doi">10.1287/msom.2022.1160</ArticleId></ArticleIdList></Reference><Reference><Citation>Bertsimas D, Allison K, and Pulleyblank WR (2016). The analytics edge. Dynamic Ideas LLC; Charlestown, MA.</Citation></Reference><Reference><Citation>Bertsimas D, Digalakis V Jr, Jacquillat A, Li ML, and Previero A (2022). Where to locate COVID-19 mass vaccination facilities? Naval Research Logistics (NRL) 69(2), 179–200, 10.1002/nav.22007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/nav.22007</ArticleId><ArticleId IdType="pmc">PMC8441649</ArticleId><ArticleId IdType="pubmed">38607841</ArticleId></ArticleIdList></Reference><Reference><Citation>Bertsimas D, Ivanhoe J, Jacquillat A, Li M, Previero A, Lami OS, and Bouardi HT (2020). Optimizing vaccine allocation to combat the COVID-19 Pandemic. medRxiv, 10.1101/2020.11.17.20233213.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.11.17.20233213</ArticleId></ArticleIdList></Reference><Reference><Citation>Bogart LM, Ojikutu BO, Tyagi K, Klein DJ, Mutchler MG, Dong L, Lawrence SJ, Thomas DR, and Kellman S (2021). COVID-19 related medical mistrust, health impacts, and potential vaccine hesitancy among black americans living with HIV. Journal of Acquired Immune Deficiency Syndromes (1999) 86(2), 200, 10.1097/QAI.0000000000002570.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/QAI.0000000000002570</ArticleId><ArticleId IdType="pmc">PMC7808278</ArticleId><ArticleId IdType="pubmed">33196555</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonney M and Jaber MY (2011). Environmentally responsible inventory models: Non-classical models for a non-classical era. International Journal of Production Economics 133(1), 43–53, 10.1016/j.ijpe.2009.10.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijpe.2009.10.033</ArticleId></ArticleIdList></Reference><Reference><Citation>Bozkir CD, Ozmemis C, Kurbanzade AK, Balcik B, Gunes ED, and Tuglular S (2023). Capacity planning for effective cohorting of hemodialysis patients during the coronavirus pandemic: A case study. European Journal of Operational Research 304(1), 276–291, 10.1016/j.ejor.2021.10.039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejor.2021.10.039</ArticleId><ArticleId IdType="pmc">PMC8556688</ArticleId><ArticleId IdType="pubmed">34744293</ArticleId></ArticleIdList></Reference><Reference><Citation>Bravo F, Hu J, and Long E (2022). Optimal COVID-19 Vaccination facility location. Available at SSRN 4008669, 10.2139/ssrn.4008669.</Citation><ArticleIdList><ArticleId IdType="doi">10.2139/ssrn.4008669</ArticleId></ArticleIdList></Reference><Reference><Citation>Bubar KM, Reinholt K, Kissler SM, Lipsitch M, Cobey S, Grad YH, and Larremore DB (2021). Model-informed COVID-19 Vaccine prioritization strategies by age and serostatus. Science 371(6532), 916–921, 10.1126/science.abe6959.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abe6959</ArticleId><ArticleId IdType="pmc">PMC7963218</ArticleId><ArticleId IdType="pubmed">33479118</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabezas X, García S, Martin-Barreiro C, Delgado E, and Leiva V (2021). A two-stage location problem with order solved using a lagrangian algorithm and stochastic programming for a potential use in COVID-19 Vaccination based on sensor-related data. Sensors 21(16), 5352, 10.3390/s21165352.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/s21165352</ArticleId><ArticleId IdType="pmc">PMC8401739</ArticleId><ArticleId IdType="pubmed">34450794</ArticleId></ArticleIdList></Reference><Reference><Citation>Cano-Marin E, Ribeiro-Soriano D, Mardani A, and Gonzalez-Tejero CB (2023). Exploring the challenges of the COVID-19 vaccine supply chain using social media analytics: A global perspective. Sustainable Technology and Entrepreneurship 2(3), 100047, 10.1016/j.stae.2023.100047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stae.2023.100047</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao C, Liu J, Liu Y, Wang H, and Liu M (2023). Digital twin-driven robust bi-level optimisation model for COVID-19 medical waste location-transport under circular economy. Computers &amp; Industrial Engineering, 109107, 10.1016/j.cie.2023.109107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cie.2023.109107</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaturvedi D and Chakravarty U (2021). Predictive analysis of COVID-19 eradication with vaccination in India, Brazil, and USA. Infection, Genetics and Evolution 92, 104834, 10.1016/j.meegid.2021.104834.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.meegid.2021.104834</ArticleId><ArticleId IdType="pmc">PMC8010329</ArticleId><ArticleId IdType="pubmed">33798755</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J, Hoops S, Marathe A, Mortveit H, Lewis B, Venkatramanan S, Haddadan A, Bhattacharya P, Adiga A, Vullikanti A, et al. (2021). Prioritizing allocation of COVID-19 Vaccines based on social contacts increases vaccination effectiveness. MedRxiv, 10.1101/2021.02.04.21251012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.02.04.21251012</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X, Li M, Simchi-Levi D, and Zhao T (2020). Allocation of COVID-19 Vaccines under limited supply. MedRxiv, 10.1101/2020.08.23.20179820.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.08.23.20179820</ArticleId></ArticleIdList></Reference><Reference><Citation>Chick SE, Mamani H, and Simchi-Levi D (2008). Supply chain coordination and Influenza Vaccination. Operations Research 56(6), 1493–1506, 10.1287/opre.1080.0527.</Citation><ArticleIdList><ArticleId IdType="doi">10.1287/opre.1080.0527</ArticleId></ArticleIdList></Reference><Reference><Citation>Chowdhury NR, Ahmed M, Mahmud P, Paul SK, and Liza SA (2022). Modeling a sustainable vaccine supply chain for a healthcare system. Journal of Cleaner Production 370, 133423, 10.1016/j.jclepro.2022.133423.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclepro.2022.133423</ArticleId><ArticleId IdType="pmc">PMC9372915</ArticleId><ArticleId IdType="pubmed">35975192</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai T and Song J-S (2021). Transforming COVID-19 Vaccines into vaccination. Health Care Management Science 24(3), 455–459, 10.2139/ssrn.3797192.</Citation><ArticleIdList><ArticleId IdType="doi">10.2139/ssrn.3797192</ArticleId><ArticleId IdType="pmc">PMC8206869</ArticleId><ArticleId IdType="pubmed">34132977</ArticleId></ArticleIdList></Reference><Reference><Citation>Dastgoshade S, Shafiee M, Klibi W, and Shishebori D (2022). Social equity-based distribution networks design for the COVID-19 Vaccine. International Journal of Production Economics 250, 108684, 10.1016/j.ijpe.2022.108684.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijpe.2022.108684</ArticleId><ArticleId IdType="pmc">PMC9627533</ArticleId><ArticleId IdType="pubmed">36337682</ArticleId></ArticleIdList></Reference><Reference><Citation>Emu M, Chandrasekaran D, Mago V, and Choudhury S (2021). Validating optimal COVID-19 Vaccine distribution models. In International Conference on Computational Science, pp. 352–366. Springer, 10.48550/arXiv.2102.04251.</Citation><ArticleIdList><ArticleId IdType="doi">10.48550/arXiv.2102.04251</ArticleId></ArticleIdList></Reference><Reference><Citation>Enayati S, Campbell JF, and Li H (2023). Vaccine distribution with drones for less developed countries: A case study in Vanuatu. Vaccine: X 14, 100312, 10.1016/j.jvacx.2023.100312.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvacx.2023.100312</ArticleId><ArticleId IdType="pmc">PMC10205531</ArticleId><ArticleId IdType="pubmed">37234593</ArticleId></ArticleIdList></Reference><Reference><Citation>Enayati S, Li H, Campbell JF, and Pan D (2023). Multimodal vaccine distribution network design with drones. Transportation Science, 10.1287/trsc.2023.1205.</Citation><ArticleIdList><ArticleId IdType="doi">10.1287/trsc.2023.1205</ArticleId></ArticleIdList></Reference><Reference><Citation>Enayati S and Özaltin OY (2020). Optimal Influenza Vaccine distribution with equity. European Journal of Operational Research 283(2), 714–725, 10.1016/j.ejor.2019.11.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejor.2019.11.025</ArticleId></ArticleIdList></Reference><Reference><Citation>Fadaki M, Abareshi A, Far SM, and Lee PT-W (2022). Multi-period vaccine allocation model in a pandemic: A case study of COVID-19 in Australia. Transportation Research Part E: Logistics and Transportation Review 161, 102689, 10.1016/j.tre.2022.102689.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tre.2022.102689</ArticleId><ArticleId IdType="pmc">PMC8995313</ArticleId><ArticleId IdType="pubmed">35431604</ArticleId></ArticleIdList></Reference><Reference><Citation>Forman R, Shah S, Jeurissen P, Jit M, and Mossialos E (2021). COVID-19 Vaccine challenges: What have we learned so far and what remains to be done? Health Policy 125(5), 553–567, 10.1016/j.healthpol.2021.03.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.healthpol.2021.03.013</ArticleId><ArticleId IdType="pmc">PMC7997052</ArticleId><ArticleId IdType="pubmed">33820678</ArticleId></ArticleIdList></Reference><Reference><Citation>Foy BH, Wahl B, Mehta K, Shet A, Menon GI, and Britto C (2021). Comparing COVID-19 Vaccine allocation strategies in India: A mathematical modelling study. International Journal of Infectious Diseases 103,431–438, 10.1016/j.ijid.2020.12.075.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.12.075</ArticleId><ArticleId IdType="pmc">PMC7834611</ArticleId><ArticleId IdType="pubmed">33388436</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujimoto AB, Keskinocak P, and Yildirim I (2021). Significance of SARS-CoV-2 specific antibody testing during COVID-19 Vaccine allocation. Vaccine 39(35), 5055–5063, 10.1016/j.vaccine.2021.06.067.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2021.06.067</ArticleId><ArticleId IdType="pmc">PMC8233959</ArticleId><ArticleId IdType="pubmed">34274126</ArticleId></ArticleIdList></Reference><Reference><Citation>Gel ES, Jehn M, Lant T, Muldoon AR, Nelson T, and Ross HM (2020). COVID-19 healthcare demand projections: Arizona. PloS one 15(12), e0242588, 10.1371/journal.pone.0242588.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0242588</ArticleId><ArticleId IdType="pmc">PMC7710107</ArticleId><ArticleId IdType="pubmed">33264308</ArticleId></ArticleIdList></Reference><Reference><Citation>Georgiadis GP and Georgiadis MC (2021). Optimal planning of the COVID-19 Vaccine supply chain. Vaccine 39(37), 5302–5312, 10.1016/j.vaccine.2021.07.068.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2021.07.068</ArticleId><ArticleId IdType="pmc">PMC8313510</ArticleId><ArticleId IdType="pubmed">34373118</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilani H and Sahebi H (2022). A data-driven robust optimization model by cutting hyperplanes on vaccine access uncertainty in COVID-19 Vaccine supply chain. Omega 110, 102637, 10.1016/j.omega.2022.102637.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.omega.2022.102637</ArticleId><ArticleId IdType="pmc">PMC8913040</ArticleId><ArticleId IdType="pubmed">35291647</ArticleId></ArticleIdList></Reference><Reference><Citation>Goodarzian F, Ghasemi P, Gunasekaren A, Taleizadeh AA, and Abraham A (2022). A sustainable-resilience healthcare network for handling COVID-19 Pandemic. Annals of Operations Research 312(2), 761–825, 10.1007/s10479--021--04238--2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10479--021--04238--2</ArticleId><ArticleId IdType="pmc">PMC8497050</ArticleId><ArticleId IdType="pubmed">34642527</ArticleId></ArticleIdList></Reference><Reference><Citation>Goodarzian F, Navaei A, Ehsani B, Ghasemi P, and Muñuzuri J (2022). Designing an integrated responsive-green-cold vaccine supply chain network using Internet-of-Things: Artificial intelligence-based solutions. Annals of Operations Research, 1–45, 10.1007/s10479--022--04713--4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10479--022--04713--4</ArticleId><ArticleId IdType="pmc">PMC9071011</ArticleId><ArticleId IdType="pubmed">35540307</ArticleId></ArticleIdList></Reference><Reference><Citation>Govindan K, Mina H, and Alavi B (2020). A decision support system for demand management in healthcare supply chains considering the epidemic outbreaks: A case study of coronavirus disease 2019 (COVID-19). Transportation Research Part E: Logistics and Transportation Review 138, 101967, 10.1016/j.tre.2020.101967.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tre.2020.101967</ArticleId><ArticleId IdType="pmc">PMC7203053</ArticleId><ArticleId IdType="pubmed">32382249</ArticleId></ArticleIdList></Reference><Reference><Citation>Gralla E, Goentzel J, and Fine C (2014). Assessing trade-offs among multiple objectives for humanitarian aid delivery using expert preferences. Production and Operations Management 23(6), 978–989, 10.1111/poms.12110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/poms.12110</ArticleId></ArticleIdList></Reference><Reference><Citation>Habibi F, Abbasi A, and Chakrabortty RK (2023). Designing an efficient vaccine supply chain network using a two-phase optimization approach: A case study of COVID-19 vaccine. International Journal of Systems Science: Operations &amp; Logistics 10(1), 2121623, 10.1080/23302674.2022.2121623.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23302674.2022.2121623</ArticleId></ArticleIdList></Reference><Reference><Citation>Hajibabai L, Hajbabaie A, Swann J, and Vergano D (2022). Using COVID-19 data on vaccine shipments and wastage to inform modeling and decision-making. Transportation Science, 10.1287/trsc.2022.1134.</Citation><ArticleIdList><ArticleId IdType="doi">10.1287/trsc.2022.1134</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasija V, Patial S, Raizada P, Thakur S, Singh P, and Hussain CM (2022). The environmental impact of mass coronavirus vaccinations: A point of view on huge COVID-19 Vaccine waste across the globe during ongoing vaccine campaigns. Science of The Total Environment 813, 151881, 10.1016/j.scitotenv.2021.151881.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.scitotenv.2021.151881</ArticleId><ArticleId IdType="pmc">PMC8609666</ArticleId><ArticleId IdType="pubmed">34826493</ArticleId></ArticleIdList></Reference><Reference><Citation>Hegde SJ, Mahmassani H, and Smilowitz K (2023). A two-regime analysis of the COVID-19 vaccine distribution process. Journal of Humanitarian Logistics and Supply Chain Management, 10.1108/JHLSCM--10--2021--0106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1108/JHLSCM--10--2021--0106</ArticleId></ArticleIdList></Reference><Reference><Citation>Hill AN and Longini IM Jr (2003). The critical vaccination fraction for heterogeneous epidemic models. Mathematical Biosciences 181(1), 85–106, 10.1016/S0025--5564(02)00129--3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0025--5564(02)00129--3</ArticleId><ArticleId IdType="pubmed">12421553</ArticleId></ArticleIdList></Reference><Reference><Citation>Hinojosa Y, Puerto J, and Fernández FR (2000). A multiperiod two-echelon multicommodity capacitated plant location problem. European Journal of Operational Research 123(2), 271–291, 10.1016/S0377--2217(99)00256--8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0377--2217(99)00256--8</ArticleId></ArticleIdList></Reference><Reference><Citation>Hovav S and Tsadikovich D (2015). A network flow model for inventory management and distribution of Influenza Vaccines through a healthcare supply chain. Operations Research for Health Care 5, 49–62, 10.1016/j.orhc.2015.05.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.orhc.2015.05.003</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu M, Zhang C, and Zhou Y (2023). First or second doses first? Vaccine allocation under limited supply. SSRN, 10.2139/ssrn.4411818.</Citation><ArticleIdList><ArticleId IdType="doi">10.2139/ssrn.4411818</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang H-C, Singh B, Morton DP, Johnson GP, Clements B, and Meyers LA (2017). Equalizing access to pandemic Influenza Vaccines through optimal allocation to public health distribution points. PloS One 12(8), e0182720, 10.1371/journal.pone.0182720.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0182720</ArticleId><ArticleId IdType="pmc">PMC5576642</ArticleId><ArticleId IdType="pubmed">28854244</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang M, Smilowitz K, and Balcik B (2012). Models for relief routing: Equity, efficiency and efficacy. Transportation Research Part E: Logistics and Transportation Review 48(1), 2–18, 10.1016/j.tre.2011.05.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tre.2011.05.004</ArticleId></ArticleIdList></Reference><Reference><Citation>Işık EE and Yildiz ST (2023). Optimizing the COVID-19 cold chain vaccine distribution network with medical waste management: A robust optimization approach. Expert Systems with Applications 229, 120510, 10.1016/j.eswa.2023.120510.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eswa.2023.120510</ArticleId><ArticleId IdType="pmc">PMC10197550</ArticleId><ArticleId IdType="pubmed">37251535</ArticleId></ArticleIdList></Reference><Reference><Citation>Jadidi M, Jamshidiha S, Masroori I, Moslemi P, Mohammadi A, and Pourahmadi V (2021). A two-step vaccination technique to limit COVID-19 spread using mobile data. Sustainable Cities and Society 70, 102886, 10.1016/j.scs.2021.102886.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.scs.2021.102886</ArticleId><ArticleId IdType="pmc">PMC7999736</ArticleId><ArticleId IdType="pubmed">33816084</ArticleId></ArticleIdList></Reference><Reference><Citation>Jahani H, Chaleshtori AE, Khaksar SMS, Aghaie A, and Sheu J-B (2022). COVID-19 Vaccine distribution planning using a congested queuing system—A real case from Australia. Transportation Research Part E: Logistics and Transportation Review 163, 102749, 10.1016/j.tre.2022.102749.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tre.2022.102749</ArticleId><ArticleId IdType="pmc">PMC9149026</ArticleId><ArticleId IdType="pubmed">35664528</ArticleId></ArticleIdList></Reference><Reference><Citation>Jarumaneeroj P, Dusadeerungsikul PO, Chotivanich T, Nopsopon T, and Pongpirul K (2022). An epidemiology-based model for the operational allocation of COVID-19 Vaccines: A case study of Thailand. Computers &amp; Industrial Engineering 167, 108031, 10.1016/j.cie.2022.108031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cie.2022.108031</ArticleId><ArticleId IdType="pmc">PMC8865938</ArticleId><ArticleId IdType="pubmed">35228772</ArticleId></ArticleIdList></Reference><Reference><Citation>Karakaya S and Balcik B (2023). Developing a national pandemic vaccination calendar under supply uncertainty. Available at SSRN 4380147, 10.2139/ssrn.4380147.</Citation><ArticleIdList><ArticleId IdType="doi">10.2139/ssrn.4380147</ArticleId></ArticleIdList></Reference><Reference><Citation>Keskinocak P, Oruc BE, Baxter A, Asplund J, and Serban N (2020). The impact of social distancing on COVID-19 spread: State of Georgia case study. PloS One 15(10), e0239798, 10.1371/journal.pone.0239798.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0239798</ArticleId><ArticleId IdType="pmc">PMC7549801</ArticleId><ArticleId IdType="pubmed">33045008</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim D, Keskinocak P, Pekgün P, and Yildirim I (2022). The balancing role of distribution speed against varying efficacy levels of COVID-19 Vaccines under variants. Scientific Reports 12(1), 1–8, 10.1038/s41598--022--11060--8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598--022--11060--8</ArticleId><ArticleId IdType="pmc">PMC9075929</ArticleId><ArticleId IdType="pubmed">35523832</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim D, Pekgün P, Yildirim İ, and Keskinocak P (2021). Resource allocation for different types of vaccines against COVID-19: Tradeoffs and synergies between efficacy and reach. Vaccine 39(47), 6876–6882, 10.1016/j.vaccine.2021.10.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2021.10.025</ArticleId><ArticleId IdType="pmc">PMC8520874</ArticleId><ArticleId IdType="pubmed">34688498</ArticleId></ArticleIdList></Reference><Reference><Citation>Klemeš JJ, Van Fan Y, Tan RR, and Jiang P (2020). Minimising the present and future plastic waste, energy and environmental footprints related to COVID-19. Renewable and Sustainable Energy Reviews 127, 109883, 10.1016/j.rser.2020.109883.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rser.2020.109883</ArticleId><ArticleId IdType="pmc">PMC7183989</ArticleId><ArticleId IdType="pubmed">34234614</ArticleId></ArticleIdList></Reference><Reference><Citation>Kohneh JN, Amirdadi M, and Teimoury E (2023). An optimization framework for COVID-19 Vaccine allocation and inventory management: A case study. Applied Soft Computing 132, 109801, 10.1016/j.asoc.2022.109801.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.asoc.2022.109801</ArticleId><ArticleId IdType="pmc">PMC9651993</ArticleId><ArticleId IdType="pubmed">36407088</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar A, Kumar G, Ramane TV, and Singh G (2022). Optimal COVID-19 vaccine stations location and allocation strategies. Benchmarking: An International Journal, 10.1108/BIJ--02--2022--0089.</Citation><ArticleIdList><ArticleId IdType="doi">10.1108/BIJ--02--2022--0089</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai X, Lu X, Yu X, and Zhu N (2021). Multi-period integrated planning for vaccination station location and medical professional assignment under uncertainty. Computers &amp; Industrial Engineering 161, 107673, 10.1016/j.cie.2021.107673.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cie.2021.107673</ArticleId></ArticleIdList></Reference><Reference><Citation>Leithäuser N, Schneider J, Johann S, Krumke SO, Schmidt E, Streicher M, and Scholz S (2021). Quantifying COVID-19 Vaccine location strategies for Germany. BMC Health Services Research 21(1), 1–18, 10.1186/s12913--021--06587--x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12913--021--06587--x</ArticleId><ArticleId IdType="pmc">PMC8346347</ArticleId><ArticleId IdType="pubmed">34362347</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Q, Norman S, Guthrie P, Gachoya J, Sebakijje J, Leftridge Z, Willis CG, Kishore A, Breakenridge M, and Spence C (2021). Strategies used to meet the challenges of mass COVID-19 Vaccination by the pharmacy department in a large academic medical center. American Journal of Health-System Pharmacy 78(18), 1724–1731,10.1093/ajhp/zxab184.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ajhp/zxab184</ArticleId><ArticleId IdType="pmc">PMC8135320</ArticleId><ArticleId IdType="pubmed">33895789</ArticleId></ArticleIdList></Reference><Reference><Citation>Li S and Aprahamian H (2023). Quantifying the benefits of customized vaccination strategies: A network-based optimization approach. Naval Research Logistics (NRL), 10.1002/nav.22134.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/nav.22134</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, Pan Y, Jiang S, Huang Q, Chen Z, Zhang M, and Zhang Z (2021). Locate vaccination stations considering travel distance, operational cost, and work schedule. Omega 101, 102236, 10.1016/j.omega.2020.102236.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.omega.2020.102236</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim J, Claypool E, Norman BA, and Rajgopal J (2016). Coverage models to determine outreach vaccination center locations in low and middle income countries. Operations Research for Health Care 9, 40–48, 10.1016/j.orhc.2016.02.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.orhc.2016.02.003</ArticleId><ArticleId IdType="pmc">PMC4899456</ArticleId><ArticleId IdType="pubmed">27335770</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim J, Norman BA, and Rajgopal J (2022). Redesign of vaccine distribution networks. International Transactions in Operational Research 29(1), 200–225, 10.1111/itor.12758.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/itor.12758</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu R, Tan C, Wu DD, and Zhao C (2023). Strategies choice for blockchain construction and coordination in vaccine supply chain. Computers &amp; Industrial Engineering, 109346.</Citation></Reference><Reference><Citation>Luo F and Mehrotra S (2023). Service center location with decision dependent utilities with an application to early stage testing and vaccination in epidemic planning. Naval Research Logistics, 10.1002/nav.22112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/nav.22112</ArticleId></ArticleIdList></Reference><Reference><Citation>Lusiantoro L, Mara S, and Rifai A (2022). A locational analysis model of the COVID-19 Vaccine distribution. Operations and Supply Chain Management: An International Journal 15(2), 240–250, 10.31387/oscm0490344.</Citation><ArticleIdList><ArticleId IdType="doi">10.31387/oscm0490344</ArticleId></ArticleIdList></Reference><Reference><Citation>MacIntyre CR, Costantino V, and Trent M (2022). Modelling of COVID-19 Vaccination strategies and herd immunity, in scenarios of limited and full vaccine supply in NSW, Australia. Vaccine 40(17), 2506–2513, 10.1016/j.vaccine.2021.04.042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2021.04.042</ArticleId><ArticleId IdType="pmc">PMC8064825</ArticleId><ArticleId IdType="pubmed">33958223</ArticleId></ArticleIdList></Reference><Reference><Citation>Mak H-Y, Dai T, and Tang CS (2022). Managing two-dose COVID-19 Vaccine rollouts with limited supply: Operations strategies for distributing time-sensitive resources. Production and Operations Management, 10.1111/poms.13862.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/poms.13862</ArticleId><ArticleId IdType="pmc">PMC9538244</ArticleId><ArticleId IdType="pubmed">36246547</ArticleId></ArticleIdList></Reference><Reference><Citation>Manupati VK, Schoenherr T, Subramanian N, Ramkumar M, Soni B, and Panigrahi S (2021). A multi-echelon dynamic cold chain for managing vaccine distribution. Transportation Research Part E: Logistics and Transportation Review 156, 102542, 10.1016/j.tre.2021.102542.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tre.2021.102542</ArticleId><ArticleId IdType="pmc">PMC8602632</ArticleId><ArticleId IdType="pubmed">34815731</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehrotra S, Rahimian H, Barah M, Luo F, and Schantz K (2020). A model of supply-chain decisions for resource sharing with an application to ventilator allocation to combat COVID-19. Naval Research Logistics (NRL) 67(5), 303–320, 10.1002/nav.21905.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/nav.21905</ArticleId><ArticleId IdType="pmc">PMC7267382</ArticleId><ArticleId IdType="pubmed">38607793</ArticleId></ArticleIdList></Reference><Reference><Citation>Minoza JMA, Bongolan VP, and Rayo JF (2021). COVID-19 agent-based model with multi-objective optimization for vaccine distribution. arXiv preprint arXiv:2101.11400, 10.48550/arXiv.2101.11400.</Citation><ArticleIdList><ArticleId IdType="doi">10.48550/arXiv.2101.11400</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohammadi M, Dehghan M, Pirayesh A, and Dolgui A (2022). Bi-objective optimization of a stochastic resilient vaccine distribution network in the context of the COVID-19 pandemic. Omega 113, 102725, 10.1016/j.omega.2022.102725.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.omega.2022.102725</ArticleId><ArticleId IdType="pmc">PMC9330510</ArticleId><ArticleId IdType="pubmed">35915776</ArticleId></ArticleIdList></Reference><Reference><Citation>Munguía-López A. d. C. and Ponce-Ortega JM (2021). Fair allocation of potential COVID-19 Vaccines using an optimization-based strategy. Process Integration and Optimization for Sustainability 5(1), 3–12, 10.1007/s41660--020--00141-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s41660--020--00141-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Orgut IS, Freeman N, Lewis D, and Parton J (2023). Equitable and effective vaccine access considering vaccine hesitancy and capacity constraints. Omega 120,102898, 10.1016/j.omega.2023.102898.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.omega.2023.102898</ArticleId><ArticleId IdType="pmc">PMC10199497</ArticleId><ArticleId IdType="pubmed">37275337</ArticleId></ArticleIdList></Reference><Reference><Citation>Oruc BE, Fujimoto A, Breiman R, and Keskinocak P (2021). Impact of prioritizing elderly and high-risk individuals during COVID-19 Vaccine allocation. pp. 10.21203/rs.3.rs--944201/v1.</Citation><ArticleIdList><ArticleId IdType="doi">10.21203/rs.3.rs--944201/v1</ArticleId></ArticleIdList></Reference><Reference><Citation>Polo G, Acosta CM, Ferreira F, and Dias RA (2015). Location-allocation and accessibility models for improving the spatial planning of public health services. PloS One 10(3), e0119190, 10.1371/journal.pone.0119190.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0119190</ArticleId><ArticleId IdType="pmc">PMC4361743</ArticleId><ArticleId IdType="pubmed">25775411</ArticleId></ArticleIdList></Reference><Reference><Citation>Radke J and Mu L (2000). Spatial decompositions, modeling and mapping service regions to predict access to social programs. Geographic Information Sciences 6(2), 105–112, 10.1080/10824000009480538.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10824000009480538</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahimian H and Mehrotra S (2019). Distributionally robust optimization: A review. arXiv preprint arXiv:1908.05659, 10.48550/arXiv.1908.05659.</Citation><ArticleIdList><ArticleId IdType="doi">10.48550/arXiv.1908.05659</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahman HF, Chakrabortty RK, Paul SK, and Elsawah S (2023). Optimising vaccines supply chains to mitigate the COVID-19 pandemic. International Journal of Systems Science: Operations &amp; Logistics 10(1), 2122757, 10.1080/23302674.2022.2122757.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23302674.2022.2122757</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao IJ and Brandeau ML (2021). Optimal allocation of limited vaccine to control an infectious disease: Simple analytical conditions. Mathematical Biosciences 337, 108621, 10.1016/j.mbs.2021.108621.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mbs.2021.108621</ArticleId><ArticleId IdType="pmc">PMC8076816</ArticleId><ArticleId IdType="pubmed">33915160</ArticleId></ArticleIdList></Reference><Reference><Citation>Rastegar M, Tavana M, Meraj A, and Mina H (2021). An inventory-location optimization model for equitable Influenza Vaccine distribution in developing countries during the COVID-19 Pandemic. Vaccine 39(3), 495–504, 10.1016/j.vaccine.2020.12.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2020.12.022</ArticleId><ArticleId IdType="pmc">PMC7833064</ArticleId><ArticleId IdType="pubmed">33342632</ArticleId></ArticleIdList></Reference><Reference><Citation>Rayhan MRI, Liza JM, and Rahman MM (2022). Assessment of COVID-19 vaccination-related medical waste management practices in Bangladesh. Plos One 17(8), e0273053, 10.1371/journal.pone.0273053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0273053</ArticleId><ArticleId IdType="pmc">PMC9387846</ArticleId><ArticleId IdType="pubmed">35980954</ArticleId></ArticleIdList></Reference><Reference><Citation>Romero-Brufau S, Chopra A, Ryu AJ, Gel E, Raskar R, Kremers W, Anderson KS, Subramanian J, Krishnamurthy B, Singh A, et al. (2021). Public health impact of delaying second dose of (BNT)162b2 or m(RNA)-1273 COVID-19 vaccine: Simulation agent based modeling study. BMJ 373, 10.1136/bmj.n1087.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1087</ArticleId><ArticleId IdType="pmc">PMC8114182</ArticleId><ArticleId IdType="pubmed">33980718</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenstrom ET, Mele J, Ivy JS, Mayorga ME, Patel MD, Lich KH, Johnson K, Delamater P, Keskinocak P, Boyce R, et al. (2022). Can vaccine prioritization reduce disparities in COVID-19 burden for historically marginalized populations? PNAS Nexus 1(1), pgab004, 10.1093/pnasnexus/pgab004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/pnasnexus/pgab004</ArticleId><ArticleId IdType="pmc">PMC9801966</ArticleId><ArticleId IdType="pubmed">36712803</ArticleId></ArticleIdList></Reference><Reference><Citation>Roy S, Dutta R, and Ghosh P (2021). Optimal time-varying vaccine allocation amid pandemics with uncertain immunity ratios. IEEE Access 9, 15110–15121, 10.1109/ACCESS.2021.3053268.</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/ACCESS.2021.3053268</ArticleId></ArticleIdList></Reference><Reference><Citation>Saadi N, Chi Y, Ghosh S, Eggo RM, McCarthy CV, Quaife M, Dawa J, Jit M, Vassall A, et al. (2021). Models of COVID-19 vaccine prioritisation: A systematic literature search and narrative review. BMC Medicine 19(1), 1–11,10.1186/s12916--021--02190--3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916--021--02190--3</ArticleId><ArticleId IdType="pmc">PMC8632563</ArticleId><ArticleId IdType="pubmed">34847950</ArticleId></ArticleIdList></Reference><Reference><Citation>Saberi Isfeedvajani M, Fares F, and Ismaili Shahroudi Moqaddam Z (2020). Ethical issues in COVID-19 Pandemic. Hospital Practices and Research 5(4), 126–133, 10.34172/hpr.2020.25.</Citation><ArticleIdList><ArticleId IdType="doi">10.34172/hpr.2020.25</ArticleId></ArticleIdList></Reference><Reference><Citation>Sallam M. (2021). COVID-19 Vaccine hesitancy Worldwide: A concise systematic review of vaccine acceptance rates. Vaccines 9(2), 160, 10.3390/vaccines9020160.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines9020160</ArticleId><ArticleId IdType="pmc">PMC7920465</ArticleId><ArticleId IdType="pubmed">33669441</ArticleId></ArticleIdList></Reference><Reference><Citation>Sampath S, Khedr A, Qamar S, Tekin A, Singh R, Green R, and Kashyap R (2021). Pandemics throughout the history. Cureus 13(9), 10.7759/cureus.18136.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.18136</ArticleId><ArticleId IdType="pmc">PMC8525686</ArticleId><ArticleId IdType="pubmed">34692344</ArticleId></ArticleIdList></Reference><Reference><Citation>Sazvar Z, Tafakkori K, Oladzad N, and Nayeri S (2021). A capacity planning approach for sustainable-resilient supply chain network design under uncertainty: A case study of vaccine supply chain. Computers &amp; Industrial Engineering 159, 107406, 10.1016/j.cie.2021.107406.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cie.2021.107406</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt H, Weintraub R, Williams MA, Miller K, Buttenheim A, Sadecki E, Wu H, Doiphode A, Nagpal N, Gostin LO, et al. (2021). Equitable allocation of COVID-19 Vaccines in the United States. Nature Medicine 27(7), 1298–1307, 10.1038/s41591--021--01379--6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591--021--01379--6</ArticleId><ArticleId IdType="pubmed">34007071</ArticleId></ArticleIdList></Reference><Reference><Citation>Seboka BT, Yehualashet DE, Belay MM, Kabthymer RH, Ali H, Hailegebreal S, Demeke AD, Amede ES, and Tesfa GA (2021). Factors influencing COVID-19 vaccination demand and intent in resource-limited settings: Based on health belief model. Risk Management and Healthcare Policy, 2743–2756, 10.2147/RMHP.S315043.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/RMHP.S315043</ArticleId><ArticleId IdType="pmc">PMC8253933</ArticleId><ArticleId IdType="pubmed">34234590</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah NH, Patel E, and Rabari K (2022). Investigation of carbon emissions due to COVID-19 Vaccine inventory. International Journal of System Assurance Engineering and Management 13(1), 409–420, 10.1007/s13198--021--01285--7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13198--021--01285--7</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah SMA, Mohammad D, Qureshi MFH, Abbas MZ, and Aleem S (2021). Prevalence, psychological responses and associated correlates of depression, anxiety and stress in a global population, during the coronavirus disease (COVID-19) pandemic. Community Mental Health Journal 57(1), 101–110, 10.1007/s10597--020--00728--y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10597--020--00728--y</ArticleId><ArticleId IdType="pmc">PMC7590908</ArticleId><ArticleId IdType="pubmed">33108569</ArticleId></ArticleIdList></Reference><Reference><Citation>Shamsi Gamchi N, Torabi SA, and Jolai F (2021). A novel vehicle routing problem for vaccine distribution using SIR epidemic model. OR Spectrum 43(1), 155–188, 10.1007/s00291--020--00609--6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00291--020--00609--6</ArticleId></ArticleIdList></Reference><Reference><Citation>Shim E. (2021). Optimal allocation of the limited COVID-19 Vaccine supply in South Korea. Journal of Clinical Medicine 10(4), 591, 10.3390/jcm10040591.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10040591</ArticleId><ArticleId IdType="pmc">PMC7914460</ArticleId><ArticleId IdType="pubmed">33557344</ArticleId></ArticleIdList></Reference><Reference><Citation>Shiri M and Ahmadizar F (2022). An equitable and accessible vaccine supply chain network in the epidemic outbreak of COVID-19 under uncertainty. Journal of Ambient Intelligence and Humanized Computing, 1–25, 10.1007/s12652--022--03865--2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12652--022--03865--2</ArticleId><ArticleId IdType="pmc">PMC9171116</ArticleId><ArticleId IdType="pubmed">35692508</ArticleId></ArticleIdList></Reference><Reference><Citation>Shukla S, Fressin F, Un M, Coetzer H, and Chaguturu SK (2022). Optimizing vaccine distribution via mobile clinics: A case study on COVID-19 Vaccine distribution to long-term care facilities. Vaccine 40(5), 734–741, 10.1016/j.vaccine.2021.12.049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2021.12.049</ArticleId><ArticleId IdType="pmc">PMC8710399</ArticleId><ArticleId IdType="pubmed">35027228</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva J, Bratberg J, and Lemay V (2021). COVID-19 and Influenza Vaccine hesitancy among college students. Journal of the American Pharmacists Association 61(6), 709–714, 10.1016/j.japh.2021.05.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.japh.2021.05.009</ArticleId><ArticleId IdType="pmc">PMC8139529</ArticleId><ArticleId IdType="pubmed">34092517</ArticleId></ArticleIdList></Reference><Reference><Citation>Sinha P, Kumar S, and Chandra C (2021). Strategies for ensuring required service level for COVID-19 herd immunity in Indian vaccine supply chain. European Journal of Operational Research, 10.1016/j.ejor.2021.03.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejor.2021.03.030</ArticleId><ArticleId IdType="pmc">PMC7979275</ArticleId><ArticleId IdType="pubmed">33776195</ArticleId></ArticleIdList></Reference><Reference><Citation>Soria-Arguello I, Torres-Escobar R, Pérez-Vicente HA, and Perea-Rivera TG (2021). A proposal mathematical model for the vaccine COVID-19 distribution network: A case study in Mexico. Mathematical Problems in Engineering 2021, 10.1155/2021/5484101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2021/5484101</ArticleId></ArticleIdList></Reference><Reference><Citation>Srivastava V, Ratna M, Ray A, Shukla S, Shrivastava V, Kothari N, Gupta A, Kukreja M, and Jandu HS (2021). Strengthening the immunization supply chain: A time-to-supply based approach to cold chain network optimization &amp; extension in Madhya Pradesh. Vaccine 39(45), 6660–6670, 10.1016/j.vaccine.2021.09.062.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2021.09.062</ArticleId><ArticleId IdType="pmc">PMC8547487</ArticleId><ArticleId IdType="pubmed">34629207</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang L, Li Y, Bai D, Liu T, and Coelho LC (2022). Bi-objective optimization for a multi-period COVID-19 Vaccination planning problem. Omega 110, 102617, 10.1016/j.omega.2022.102617.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.omega.2022.102617</ArticleId><ArticleId IdType="pmc">PMC8848572</ArticleId><ArticleId IdType="pubmed">35185262</ArticleId></ArticleIdList></Reference><Reference><Citation>Taskinsoy J. (2020). COVID-19: Is the great outbreak a sign of what the future has stowed for the human race? Available at SSRN 3597434, 10.2139/ssrn.3597434.</Citation><ArticleIdList><ArticleId IdType="doi">10.2139/ssrn.3597434</ArticleId></ArticleIdList></Reference><Reference><Citation>Tavana M, Govindan K, Nasr AK, Heidary MS, and Mina H (2021). A mathematical programming approach for equitable COVID-19 Vaccine distribution in developing countries. Annals of Operations Research, 1–34, 10.1007/s10479--021--04130--z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10479--021--04130--z</ArticleId><ArticleId IdType="pmc">PMC8172366</ArticleId><ArticleId IdType="pubmed">34099948</ArticleId></ArticleIdList></Reference><Reference><Citation>Thul L and Powell W (2023). Stochastic optimization for vaccine and testing kit allocation for the COVID-19 Pandemic. European Journal of Operational Research 304(1), 325–338, 10.1016/j.ejor.2021.11.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejor.2021.11.007</ArticleId><ArticleId IdType="pmc">PMC8580866</ArticleId><ArticleId IdType="pubmed">34785854</ArticleId></ArticleIdList></Reference><Reference><Citation>Troiano G and Nardi A (2021). Vaccine hesitancy in the era of COVID-19. Public Health 194, 245–251, 10.1016/j.puhe.2021.02.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.puhe.2021.02.025</ArticleId><ArticleId IdType="pmc">PMC7931735</ArticleId><ArticleId IdType="pubmed">33965796</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker J, Paul P, Dooling K, Oliver S, Prasad P, Steele M, Gastañaduy PA, Johansson MA, Biggerstaff M, and Slayton RB (2022). Modeling strategies for the allocation of SARS-CoV-2 Vaccines in the united states. Vaccine 40(14), 2134–2139, 10.1016/j.vaccine.2022.02.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2022.02.015</ArticleId><ArticleId IdType="pmc">PMC8818403</ArticleId><ArticleId IdType="pubmed">35260267</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, Jiang R, and Qi M (2023). A robust optimization problem for drone-based equitable pandemic vaccine distribution with uncertain supply. Omega 119, 102872, 10.1016/j.omega.2023.102872.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.omega.2023.102872</ArticleId><ArticleId IdType="pmc">PMC10028219</ArticleId><ArticleId IdType="pubmed">37020741</ArticleId></ArticleIdList></Reference><Reference><Citation>Westerink-Duijzer E. (2017). Mathematical optimization in vaccine allocation.</Citation></Reference><Reference><Citation>World Health Organization (2023). WHO Coronavirus (COVID-19) Dashboard.</Citation></Reference><Reference><Citation>Xu X, Rodgers MD, and Guo WG (2021). A hub-and-spoke design for ultra-cold COVID-19 Vaccine distribution. Vaccine 39(41), 6127–6136, 10.1016/j.vaccine.2021.08.069.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2021.08.069</ArticleId><ArticleId IdType="pmc">PMC8384589</ArticleId><ArticleId IdType="pubmed">34509324</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang H, Sürer Ö, Duque D, Morton DP, Singh B, Fox SJ, Pasco R, Pierce K, Rathouz P, Valencia V, et al. (2021). Design of COVID-19 staged alert systems to ensure healthcare capacity with minimal closures. Nature Communications 12(1), 3767, 10.1038/s41467--021--23989--x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467--021--23989--x</ArticleId><ArticleId IdType="pmc">PMC8213780</ArticleId><ArticleId IdType="pubmed">34145252</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang T, Deng W, Liu Y, and Deng J (2022). Comparison of health-oriented cross-regional allocation strategies for the COVID-19 Vaccine: A mathematical modelling study. Annals of Medicine 54(1), 941–952, 10.1080/07853890.2022.2060522.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07853890.2022.2060522</ArticleId><ArticleId IdType="pmc">PMC9004521</ArticleId><ArticleId IdType="pubmed">35393922</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y, Bidkhori H, and Rajgopal J (2021). Optimizing vaccine distribution networks in low and middle-income countries. Omega 99, 102197, 10.1016/j.omega.2020.102197.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.omega.2020.102197</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y and Rajgopal J (2021). Outreach strategies for vaccine distribution: A multi-period stochastic modeling approach. In Operations Research Forum, Volume 2, pp. 1–26. Springer, 10.1007/s43069-021-00064-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s43069-021-00064-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Yarmand H, Ivy JS, Denton B, and Lloyd AL (2014). Optimal two-phase vaccine allocation to geographically different regions under uncertainty. European Journal of Operational Research 233(1), 208–219, 10.1016/j.ejor.2013.08.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejor.2013.08.027</ArticleId></ArticleIdList></Reference><Reference><Citation>Yucesoy E, Coban E, and Balcik B (2022). Mobile vaccination clinic routing problem. 12th Annual International Conference on Industrial Engineering and Operations Management 12(1), 1207–1216, 10.46254/AN12.20220212.</Citation><ArticleIdList><ArticleId IdType="doi">10.46254/AN12.20220212</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang C, Li Y, Cao J, and Wen X (2022). On the mass COVID-19 vaccination scheduling problem. Computers &amp; Operations Research 141, 105704, 10.1016/j.cor.2022.105704.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cor.2022.105704</ArticleId><ArticleId IdType="pmc">PMC8783438</ArticleId><ArticleId IdType="pubmed">35095172</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>